Department of Radiology, Diagnostic and Interventional Radiology, University of Tübingen, 72076 Germany.
Department of Internal Medicine III, Cardiology and Angiology, University of Tübingen, 72076 Germany.
Diagn Interv Imaging. 2023 Nov;104(11):552-559. doi: 10.1016/j.diii.2023.07.005. Epub 2023 Aug 5.
The purpose of this study was to assess the diagnostic capabilities of cardiac magnetic resonance (CMR) T2* mapping in detecting incidental hepatic and cardiac iron overload.
Patients with various clinical indications for CMR examination were consecutively included at a single center from January 2019 to April 2023. All patients underwent T2* mapping at 1.5 T in a single mid-ventricular short-axis as part of a comprehensive routine CMR protocol. T2* measurements were performed of the heart (using a region-of-interest in the interventricular septum) and the liver, categorized according to the severity of iron overload. The degree of cardiac iron overload was categorized as mild (15 ms < T2* < 20 ms), moderate (10 ms < T2* < 15 ms) and severe (T2* < 10 ms). The degree of hepatic iron overload was categorized as mild (4 ms < T2* < 8 ms), moderate (2 ms < T2* < 4 ms), severe (T2* < 2 ms). Image quality and inter-reader agreement were assessed using intraclass correlation coefficient (ICC).
CMR examinations from 614 patients (374 men, 240 women) with a mean age of 50 ± 18 (standard deviation) years were fully evaluable. A total of 24/614 patients (3.9%) demonstrated incidental hepatic iron overload; of these, 22/614 patients (3.6%) had mild hepatic iron overload, and 2/614 patients (0.3%) had moderate hepatic iron overload. Seven out of 614 patients (1.1%) had incidental cardiac iron overload; of these, 5/614 patients (0.8%) had mild iron overload, 1/614 patients (0.2%) had moderate iron overload, and 1/614 patients (0.2%) had severe iron overload. Good to excellent inter-reader agreement was observed for the assessment of T2* values (ICC, 0.90 for heart [95% confidence interval: 0.88-0.91]; ICC, 0.91 for liver [95% confidence interval: 0.89-0.92]).
Analysis of standard CMR T2* maps detects incidental cardiac and hepatic iron overload in 1.1% and 3.9% of patients, respectively, which may have implications for further patient management. Therefore, despite an overall low number of incidental abnormal findings, T2* imaging may be included in a standardized comprehensive CMR protocol.
本研究旨在评估心脏磁共振(CMR)T2* 映射在检测偶发性肝和心脏铁过载方面的诊断能力。
本研究于 2019 年 1 月至 2023 年 4 月在一家单中心连续纳入因各种临床指征而接受 CMR 检查的患者。所有患者均在 1.5 T 下进行单次中室短轴 T2* 映射,作为综合常规 CMR 方案的一部分。使用室间隔 ROI 对心脏(T2*)和肝脏进行 T2* 测量,并根据铁过载的严重程度进行分类。心脏铁过载程度分为轻度(15 ms < T2* < 20 ms)、中度(10 ms < T2* < 15 ms)和重度(T2* < 10 ms)。肝脏铁过载程度分为轻度(4 ms < T2* < 8 ms)、中度(2 ms < T2* < 4 ms)、重度(T2* < 2 ms)。使用组内相关系数(ICC)评估图像质量和读者间一致性。
共对 614 例患者(374 例男性,240 例女性)的 CMR 检查进行了全面评估,这些患者的平均年龄为 50 ± 18(标准差)岁。共有 24/614 例患者(3.9%)出现偶发性肝铁过载;其中,22/614 例患者(3.6%)为轻度肝铁过载,2/614 例患者(0.3%)为中度肝铁过载。614 例患者中有 7 例(1.1%)出现偶发性心脏铁过载;其中,5/614 例患者(0.8%)为轻度铁过载,1/614 例患者(0.2%)为中度铁过载,1/614 例患者(0.2%)为重度铁过载。T2* 值评估的读者间一致性良好到优秀(ICC,心脏为 0.90 [95%置信区间:0.88-0.91];ICC,肝脏为 0.91 [95%置信区间:0.89-0.92])。
分析标准 CMR T2* 图谱可分别在 1.1%和 3.9%的患者中检测到偶发性心脏和肝脏铁过载,这可能对进一步的患者管理具有重要意义。因此,尽管总的异常发现数量较低,但 T2* 成像可能被纳入标准化的综合 CMR 方案中。